Iovance Biotherapeutics, Inc. IOVA Business Segments — General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s business segments — general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s business segments — general and administrative expense?
- Iovance Biotherapeutics, Inc. (IOVA) reported business segments — general and administrative expense of $18.7M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s business segments — general and administrative expense changed year-over-year?
- Iovance Biotherapeutics, Inc.'s business segments — general and administrative expense decreased by 5.8% year-over-year, from $19.86M to $18.7M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s business segments — general and administrative expense?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s business segments — general and administrative expense has grown at a -4.7% compound annual growth rate (CAGR), from $78.4M to $71.25M.
- What does business segments — general and administrative expense mean?
- This covers the overhead costs associated with corporate functions, including legal, human resources, and executive management. It serves as a measure of the company's operational discipline and the efficiency of its administrative support structure.